Paul Cislo

No ORCID on file · 3 papers in corpus
article 2025
Attribute preferences associated with gonadotropin-releasing hormone agonists/antagonists among women with endometriosis in the United States
Women's health (London, England) ·doi:10.1177/17455057251331700

BACKGROUND: Endometriosis symptoms have multifaceted manifestations, and there are few approved nonsurgical treatment options. Gonadotropin-releasing hormone (GnRH) agonists/antagonists for endometriosis vary on efficacy, safety profile, an…

article 2022
P-315 The importance of treatment features beyond pain reduction associated with gonadotropin-releasing hormone analogues from the patient perspective
·doi:10.1093/humrep/deac107.300

Abstract Study question Beyond reducing pain, how do women with moderate-severe-endometriosis pain prioritize treatment features and outcomes associated with gonadotropin-releasing hormone (GnRH) analogues? Summary answer Moderate-severe-en…

article 2022
PCR291 Preferences for Key Features of Gonadotropin-Releasing Hormone Analogues Among Women With Endometriosis in the United States
·doi:10.1016/j.jval.2022.09.2224